Sigma-1 Receptor Agonists as Potential Treatment Options for Autism Spectrum Disorders: Pre-clinical Studies with ANAVEX 2-73 in a Fragile X Model.

Gordon Research Conference for Fragile X and Autism-Related Disorders, Mount Snow, VT

Patricia Cogram, Daniel Klamer, Nell Rebowe, Jeffrey Sprouse, Christopher U. Missling

View Poster

Share this: